Reuters logo
7 months ago
BRIEF-OncoCyte provides updated timelines on diagnostic test development and commercialization plans
January 4, 2017 / 12:11 PM / 7 months ago

BRIEF-OncoCyte provides updated timelines on diagnostic test development and commercialization plans

1 Min Read

Jan 4 (Reuters) - OncoCyte Corp

* OncoCyte provides updated timelines on diagnostic test development and commercialization plans

* Breast cancer test development three to six months ahead of schedule; commercial launch possible in mid to late 2018

* Lung cancer test development two to three months behind schedule; commercial launch planned for second half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below